PSPeter Sagmeister

Peter Sagmeister

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peter Sagmeister has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Autonomous Lipid Nanoparticle Engineering

    by Peter Sagmeister, Aniket Udepurkar, Cedric Devos, Joy I. Ren, Konstantinos Zinelis, Sofiya Chubich, Krystian Ganko, Andy Y. Liu, Dylan Nguyen, Richard D. Braatz, et al.

    Lipid nanoparticles (LNPs) are the leading vehicles for encapsulating and delivering nucleic acid therapeutics. Yet, their process development remains labor-intensive and empirical, constrained by coupled quality attributes and limited mechanistic insight. We present an autonomous, pilot-scale platform for accelerating LNP process development by identifying critical process parameters (CPPs) that produce LNPs with target size attributes. The platform combines a size-control production method with inline dynamic light scattering (DLS) for real-time feedback, enabling closed-loop experimentation and accelerated optimization. With built-in automated design of experiments, dynamic parameter sweeps, and Bayesian optimization, the platform enables rapid, data-rich exploration of complex design spaces. We demonstrate that the platform rapidly maps complex process–property relationships for loaded LNPs, while minimizing experimental burden. The resulting data-rich outputs were used to develop a predictive model that quantitatively links process parameters to particle quality attributes. Operable in fully autonomous mode, the platform provides a scalable and flexible framework for rational LNP manufacturing and accelerates the broader development of nucleic acid therapeutics.

  • Particle Engineering in a Continuous Crystallizer Cascade

    by Giovanni Aprile, Prem K. Reddy, Rajan R. Bhawnani, Cedric Devos, Peter Sagmeister, Aniket Udepurkar, Yuma Miyai, Daanyaal Sajed, Aarna Jindal, Bruno Marco Inzillo, et al.

    Crystallization is central to the purification and manufacturing of nearly all small-molecule pharmaceuticals. However, continuous crystallization remains sparsely adopted, in part due to the lack of standardized off-the-shelf platforms (≤100 mL) for reproducible development. This study reports the benchmarking of a continuous tower crystallizer (TWC) that constitutes a cascade of 10 mixed-suspension, mixed-product removal (MSMPR) crystallizers to approach plug-flow-like residence time distribution (RTD) in a compact and robust setup (≤80 mL). Using ketoconazole, an agglomeration-prone active pharmaceutical ingredient (API), as a case study, the TWC’s particle engineering capability is compared to a conventional single-tank MSMPR (with similar total volume) utilized as baseline. The advanced supersaturation control achieved in the cascade enables shifting the broad bimodal crystal size distribution (CSD, D90 = 225 μm, span = 4.5) to a unimodal CSD (D90 = 57 μm, span = 3.2) while significantly increasing process yield from 66% (MSMPR) to 90% (TWC). This tunability was further demonstrated through a proof-of-concept for distributed antisolvent addition in the TWC (D90 = 44 μm, span = 2.7).

  • Hydrogenation Process Development in a Data-Rich Environment

    by Peter Sagmeister, Kensaku Matsunami, Giovanni Aprile, Darren A. Whitaker, Mohammed Janoudi, Thomas Toupy, Adrian Ramirez Galilea, Neda Nazemifard, Charles D. Papageorgiou, Aparajith Bhaskar, et al.

  • Automation in Pharmaceutical Crystallization

    by Giovanni Aprile, Peter Sagmeister, Cedric Devos, Aniket Udepurkar, Francesco Destro, Fateme Molajafari, Torsten Stelzer, Hamza Youssef Ismail, Daniel J. Griffin, Richard D. Braatz, et al.


  • Open Access

    Understanding Size Distributions during Lipid Nanoparticle Manufacturing through Mechanistic Modeling

    by Saikat Mukherjee, Sunkyu Shin, Cedric Devos, Aniket Udepurkar, Peter Sagmeister, Bernhardt L. Trout, Allan S. Myerson, Richard D. Braatz

    Recent breakthroughs in messenger RNA (mRNA) therapeutics have highlighted the importance of lipid nanoparticles (LNPs) as delivery vehicles that protect fragile mRNA and facilitate cellular uptake. While manufacturing technologies that rely on self-assembly through mixing, including microfluidic systems and turbulent jet mixers, have enabled scalable production, a first-principles model explaining the fundamental mechanisms responsible for LNP size and its distribution has remained elusive. This has limited predictive process control and optimization. To address this gap, we present here a model based on crystallization of a lipid during turbulent mixing of water–ethanol, employing population balance equations to predict particle size distributions. The model successfully predicts the influence of key operating parameters including total flow rate, flow rate ratio, and lipid concentration, demonstrating favorable comparison with experimental results and enabling the development of predictive manufacturing processes for consistent critical quality attributes. The mechanistic understanding provides the foundation necessary to optimize manufacturing of LNPs used as delivery agents of mRNA vaccines, which extends beyond the current application to the broader field of nucleic acid therapeutics.


  • Manufacturing mRNA-Loaded Lipid Nanoparticles with Precise Size and Morphology Control

    by Cedric Devos, Aniket Udepurkar, Peter Sagmeister, Ariana S. Hodlewsky, Julie Chen, Andrew Hatas, Nicole Ostrovsky, Mushriq Al-Jazrawe, Joy I. Ren, Andy Y. Liu, et al.

    Lipid nanoparticles (LNPs) are the leading platform for delivering nucleic acid therapeutics, produced by rapidly mixing lipids in ethanol with nucleic acid cargo in an aqueous buffer. LNP production is often approached with a mixing-focused mindset that reduces the entire self-assembly process to a single step, obscuring the relationship between the process inputs and LNP properties. Here, we present a method for producing mRNA-loaded LNPs, with independent and predictive control over both the size and morphology and without compromising other quality attributes. By decoupling particle design from mixing and formulation changes, this method enables the rational engineering of LNPs with defined properties. The method leverages mixing under high fusogenicity conditions, achieved by modulating the solvent composition, followed by timed postinjection of an aqueous buffer to kinetically arrest LNPs at the desired properties. We demonstrate the method using benchmark LNP formulations in an impinging jet mixer, a state-of-the-art technology for LNP manufacturing. The resulting LNPs exhibit up to an 8-fold increase in in vitro transfection efficacy compared to those produced by the conventional method. In addition, the method facilitates quality control and supports predictive modeling and rational process translation.


  • Open Access

    FlowMat: a toolbox for modeling flow reactors using physics-based and machine learning approaches for modular simulation, parameter identification, and reactor optimization

    by Sebastian Knoll, Klara Silber, Jason D. Williams, Peter Sagmeister, Christopher A. Hone, C. Oliver Kappe, Martin Steinberger, Martin Horn

    This paper introduces a versatile, open-source MATLAB/Simulink toolbox for modeling and optimizing flow reactors. The toolbox features a modular architecture and an intuitive drag-and-drop interface, supporting a range of different modeling approaches, including physics-based, data-driven, and hybrid models such as physics-informed neural networks. We detail the toolbox's implementation and demonstrate its capabilities through real-world applications, including the simulation of flow reactors, identification of reaction parameters using experimental data (e.g., transient data), and optimization of reactor operating points and configurations. Experimental validations illustrate the practical applicability and effectiveness of the toolbox, making it a valuable resource for researchers and engineers in the field with the potential of reducing the cost and time required for parameter determination and reactor optimization.


  • Top Cited Papers

    Structure and Morphology of Lipid Nanoparticles for Nucleic Acid Drug Delivery: A Review

    by Aniket Udepurkar, Cedric Devos, Peter Sagmeister, Francesco Destro, Pavan Inguva, Soroush Ahmadi, Etienne Boulais, Yufeng Quan, Richard D. Braatz, Allan S. Myerson

    Lipid nanoparticles (LNPs) are a clinically proven platform for protecting and delivering nucleic acid-based therapeutics. These multicomponent particles self-assemble into a core-shell structure with the nucleic acid cargo encapsulated in its core. Despite considerable research efforts to establish structure-efficacy relationships, their morphological and structural characteristics─particularly their internal composition and distribution─remain elusive. This uncertainty arises from several factors, including challenges in characterization, the dynamic nature of LNPs, sample heterogeneity, and poorly understood formulation-structure relationships. This review highlights the current state of research on the structure and morphology of LNPs, characterization techniques, and ongoing efforts to elucidate how formulation parameters affect the structural and morphological LNP properties.


  • Open Access

    Simultaneous reaction- and analytical model building using dynamic flow experiments to accelerate process development

    by Peter Sagmeister, Lukas Melnizky, Jason D. Williams, C. Oliver Kappe

    By making use of a flow standard addition approach and dynamic flow experiments, we present an automated workflow for the fitting of analytical and reaction models, followed by in silico optimization, within one working day.


  • Open Access

    An Automated Dual Modeling Approach to Accelerate Reaction Analysis and Optimization

    by Peter Sagmeister, Lukas Melnizky, Jason Williams, C. Oliver Kappe

    In modern pharmaceutical research, the demand for expeditious development of synthetic routes to active pharmaceutical ingredients (APIs) has led to a paradigm shift towards data-rich process development. Conventional methodologies en-compass prolonged timelines for reaction and analytical model developments. Both method developments are separated into different departments and often require an iterative process to optimize the models. Addressing this issue, we intro-duce an innovative dual modeling approach, seamlessly integrating the development of a Process Analytical Technology (PAT) strategy with reaction optimization. This integrated approach is exemplified in diverse amidation reactions and the synthesis of the API benznidazole. The platform, characterized by a high degree of automation and minimal operator in-volvement, achieves PAT calibration through a “standard addition” approach. Dynamic experiments are executed to screen a broad process space and gather data for fitting kinetic parameters. Employing a Julia-coded software program facilitates rapid kinetic parameter fitting and in-situ optimization within minutes. This highly automated workflow not only expedites the understanding and optimization of chemical processes, but also holds significant promise for time and resource savings within the pharmaceutical industry.